Boehringer Ingelheim Press Releases

Quick access for journalists to the latest press releases that cover corporate, research & development, prescription, industrial, animal health and consumer pharmaceutical news.

Information for...

General Use Patients or Carers Health Care Professionals in the US Health Care Professionals outside the US and UK Journalists Jobseekers

PRESS RELEASE

Press Release Overview

Here you can find an overview list of our recent Press Releases.

Read more
- Enleofen
PRESS RELEASE 09 Jan 2020 at 13:00

Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases

Read more on
Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases
PRESS RELEASE 03 Jan 2020 at 09:00

Boehringer Ingelheim introduces DiaTEC, a new and proprietary purification technology for Ingelvac CircoFLEX^{^®}

Read more on
Boehringer Ingelheim introduces DiaTEC, a new and proprietary purification technology for Ingelvac CircoFLEX^{^®}
PRESS RELEASE 30 Dec 2019 at 10:30

Milestone for Biopharmaceuticals in China

Read more on
Milestone for Biopharmaceuticals in China
PRESS RELEASE 09 Dec 2019 at 09:00

Boehringer Ingelheim announces 2020 ‘BVDzero Case Awards’

Read more on
Boehringer Ingelheim announces 2020 ‘BVDzero Case Awards’
PRESS RELEASE 05 Nov 2019 at 09:00

The new African Swine Fever Manual published

Read more on
The new African Swine Fever Manual published
- KRAS
PRESS RELEASE 29 Oct 2019 at 15:00

Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing

Read more on
Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing
PRESS RELEASE 29 Oct 2019 at 11:30

Boehringer Ingelheim joins forces with The Defeat-NCD Partnership to fight non-communicable diseases

Read more on
Boehringer Ingelheim joins forces with The Defeat-NCD Partnership to fight non-communicable diseases
PRESS RELEASE 07 Oct 2019 at 09:00

Winners of the 2019 European PRRS Research Award announced

Read more on
Winners of the 2019 European PRRS Research Award announced
PRESS RELEASE 01 Oct 2019 at 09:00

Boehringer Ingelheim obtains EMA authorization for Reprocyc^{^®} ParvoFLEX, a new porcine parvovirus vaccine

Read more on
Boehringer Ingelheim obtains EMA authorization for Reprocyc^{^®} ParvoFLEX, a new porcine parvovirus vaccine
PRESS RELEASE 30 Sep 2019 at 08:00

INBUILD^® meets primary endpoint - study evaluated nintedanib in patients across a range of progressive fibrosing interstitial lung diseases¹

Read more on
INBUILD^® meets primary endpoint - study evaluated nintedanib in patients across a range of progressive fibrosing interstitial lung diseases¹
PRESS RELEASE 27 Sep 2019 at 08:30

New therapeutic indications for NexGard^®, NexGard SPECTRA^® and Broadline^® approved by EMA

Read more on
New therapeutic indications for NexGard^®, NexGard SPECTRA^® and Broadline^® approved by EMA
PRESS RELEASE 26 Sep 2019 at 08:00

Boehringer Ingelheim donates vaccines to help fight rabies

Read more on
Boehringer Ingelheim donates vaccines to help fight rabies
PRESS RELEASE 20 Sep 2019 at 14:00

Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases

Read more on
Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases
PRESS RELEASE 20 Sep 2019 at 13:00

Boehringer Ingelheim breaks ground on its strategic vaccine production center for veterinary public health

Read more on
Boehringer Ingelheim breaks ground on its strategic vaccine production center for veterinary public health
PRESS RELEASE 12 Sep 2019 at 09:00

Boehringer Ingelheim showcases its leading avian vaccines and services at WVPAC 2019

Read more on
Boehringer Ingelheim showcases its leading avian vaccines and services at WVPAC 2019
PRESS RELEASE 04 Sep 2019 at 09:00

Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound

Read more on
Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound
PRESS RELEASE 03 Sep 2019 at 08:00

Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes

Read more on
Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes
PRESS RELEASE 26 Aug 2019 at 13:53

Change in the Board of Managing Directors at Boehringer Ingelheim

Read more on
Change in the Board of Managing Directors at Boehringer Ingelheim
PRESS RELEASE 19 Aug 2019 at 10:00

Social entrepreneurs improve healthcare access across the African continent

Read more on
Social entrepreneurs improve healthcare access across the African continent